Jump to content

Telomestatin

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by LegionMammal978 (talk | contribs) at 15:18, 29 April 2021 (add IUPAC name). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Telomestatin
Names
Preferred IUPAC name
(84R)-65,75-Dimethyl-84,85-dihydro-1(2,4),2,3,4,5,6,7(4,2)-heptakis([1,3]oxazolo)-8(2,4)-[1,3]thiazolocyclooctaphane
Identifiers
3D model (JSmol)
ChEMBL
  • CC1=C(C2=NC(C3=NC(C4=NC(C5=NC(C6=NC(C7=NC(C8=N[C@@]9([H])CS8)=CO7)=CO6)=CO5)=CO4)=CO3)=C(C)O2)N=C9O1
Properties
C26H14N8O7S
Molar mass 582.51 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Telomestatin is a macrocyclic chemical compound that acts by inhibiting the telomerase activity of in vitro cancer cells.[1] It was first isolated from the bacteria Streptomyces anulatus.[1] Telomestatin induces the formation of basket-type G-quadruplex (G4) structures from hybrid-type G-quadruplexes in the telomeric region. Upon formation of G4 structure there will be a decrease in the activity of the telomerase, which is involved in the replication of the telomeres and as a result the cell dies due to Hayflick type senescence.

References

[edit]
  1. ^ a b Shin-ya, Kazuo; Wierzba, Konstanty; Matsuo, Ken-ichi; Ohtani, Toshio; Yamada, Yuji; Furihata, Kazuo; Hayakawa, Yoichi; Seto, Haruo (2001). "Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus". Journal of the American Chemical Society. 123 (6): 1262–1263. doi:10.1021/ja005780q. PMID 11456694.